Febit and the Translational Genomics Research Institute have announced that TGen will evaluate Febit's Hybselect sequencing equipment in conjunction with Febit's Geniom Microarray Technology.
Febit's HybSelect technology enables selective DNA capture and elution, an efficient method to preselect sequences for next-generation sequencers.
It is based on Febit's Geniom technology and uses arrays within microfludic biochips for the selection of targeted DNA.
Geniom biochips are programmable and can contain any set of capture probes - the method combines the high performance of the latest sequencers with the efficient selection capabilities of Geniom technology.
Cord F Staehler, president of Febit, said: 'We will obtain important data from TGen that will help us as we prepare for the official introduction of HybSelect in early 2009.'
